Trial intelligence / Profile preview

Effect of Satiety Gut Hormone Modulation on Appetite After Upper GI Surgery

NCT02381249Completed

Sponsor
St James's Hospital
Start
Mar 2015
Primary completion
Mar 2018
Modality
Peptides
Countries
2
01

Overview

Randomised, double-blind trial of Octreotide long-acting injection in Malnutrition (4 arms), sponsored by St James's Hospital. Primary endpoint: Progressive ratio task breakpoint for a sweet-fat reward at 3 hours. Started Mar 2015; status: completed.

02

Drugs

Octreotide long-acting injection
03

Conditions

Malnutrition

Beyond the preview

Go deeper on NCT02381249.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02381249.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call